Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data DNA X, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
136
116
64
54.6
69.8
93.6
58.3
Cost of revenue
87.6
81.7
48.8
48.2
58.2
74.3
48.4
Gross profit
48.1
34.5
15.2
6.41
11.6
19.3
9.92
Research and development
23.2
26.1
16.2
17.7
7.97
1.77
14.2
Selling and marketing
12.2
13.9
10.4
9.57
7.27
8.77
13
General and administrative
7.22
15.1
9.83
10.3
10.7
8.27
3.1
5.41
Operating expenses
42.7
56.9
44.5
44.4
25.9
18.8
3.1
5.41
Operating income
5.39
-22.4
-29.3
-38
-14.3
0.51
-3.1
-5.41
Interest expense
0.1
0.95
Other non-operating income
-0.57
-0.54
-0.43
-0.46
0.48
-0.21
0.25
-0.9
Pre-tax income
2.03
-24.4
-30.5
-38.5
-13.9
0.28
-2.88
-7.96
Income tax
0.75
1.39
-0.52
0.17
0.18
0.37
0.23
-1.15
Income from continuing operations
-2.88
-7.96
Net income
1.28
-25.8
-29.9
-38.6
-14.1
-0.09
-33.6
-20.7
EBITDA
7.24
-18.9
-26.5
-35.9
-11.9
2.72
0.46
-1.11
EPS, basic
-461.28
-249.49
-116.67
-73.46
-8.82
-0.36
-128.37
-28.58
EPS, diluted
-461.28
-249.49
-116.67
-73.46
-8.82
-0.36
-128.37
-28.58
Shares, basic (weighted)
0.02
0.1
0.26
0.53
1.6
0.24
0.26
0.72
Shares, diluted (weighted)
0.02
0.1
0.26
0.53
1.6
0.24
0.26
0.72
Balance sheet
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
13
11.3
22.1
11.2
13.2
9.4
5.34
1.3
Receivables
18.9
10.1
4.15
10.8
22.4
25.3
4.34
Inventory
21.8
19.5
11.3
5.54
3.91
6.52
10.6
Other current assets
1.06
1.23
0.81
0.72
0.52
1.61
4.56
0.68
Total current assets
63.9
47.3
45.6
35.7
43.6
43.8
32.2
28.9
Property, plant and equipment
1.07
1.44
0.84
0.53
0.17
0.07
0.23
Lease right-of-use assets
0
0.07
0.06
Other non-current assets
2.52
2.97
2.95
0.38
0.27
Total assets
67.3
55.5
50.3
41.1
53.7
56
39.7
43.9
Accounts payable
27.3
7.23
8.86
9.47
21.1
19.8
0.74
4.03
Accrued liabilities
16.4
10.3
9.91
11.4
10.7
12.3
0.25
0.7
Deferred revenue
4.22
0.29
0.01
0.01
0.03
0.01
Short-term debt
0.3
9.82
0.18
0.15
0.15
5.07
Total current liabilities
48.2
27.6
20.5
21
32.1
32.1
43.7
50.6
Long-term debt
13.2
0.36
0.19
0.07
Lease liabilities
0.07
Total liabilities
62.2
29.9
21.9
22.5
33.6
33.7
45.4
50.6
Total debt
13.5
10.2
0.36
0.21
0.15
5.07
Paid-in capital
149
192
225
253
270
272
278
296
Retained earnings
-144
-166
-196
-235
-250
-250
-284
-304
Shareholders' equity
5.13
25.5
28.4
18.6
20
22.4
-5.7
-7.96
Total equity
5.13
25.5
28.4
18.6
20
22.4
-5.7
-7.96
Total liabilities and equity
67.3
55.5
50.3
41.1
53.7
56
39.7
43.9
Shares outstanding
0.09
0.11
3.68
1.04
2.26
0.25
0.28
1.27
Cash flow statement
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
1.28
-25.8
-29.9
-38.6
-14.1
-0.09
-33.6
-20.7
Depreciation and amortization
1.85
3.53
2.73
2.13
2.38
2.21
3.56
4.3
Stock-based compensation
0.25
6.31
1.09
1.09
1.55
1.5
1.53
1.54
Deferred income tax
0.14
0.11
0.02
-0.02
-0.14
0.07
-0.01
-1.43
Change in receivables
-8.07
8.75
5.92
-7.52
-11.6
-3.03
7.36
-1.11
Change in inventory
-12.8
-0.81
7.49
4.18
1.63
-2.61
-4.99
3.85
Change in payables
16
-20.2
1.49
0.62
11.7
-1.28
14.3
9.53
Cash from operations
3.86
-33.5
-10.6
-38.5
-12.4
-4.05
-8.49
-23.5
Capital expenditures
-0.79
-0.99
-0.01
-0.05
-0.01
-0.04
-0.21
Cash from investing
-2.55
-1.36
-0.01
-0.05
-0.01
-0.04
-0.21
Debt issued
4.99
6.37
Debt repaid
-0.22
-3.69
-4.15
-0.15
-0.07
Stock issued
8.3
38.5
25.1
27.7
14.4
0.42
4.01
13.7
Cash from financing
10.2
33.1
21.4
27.6
14.3
0.27
4.65
19.5
Net change in cash
11.5
-1.75
10.8
-10.9
1.98
-3.82
-4.05
-4.04
Free cash flow
3.07
-34.5
-10.6
-38.5
-12.4
-4.09
-8.7
Interest paid
0.55
1.04
0.26
0.1
0.02
0.03
0.95
Income taxes paid
0.26
0.27
0.08
0.09
0.15
0.04
0.13
0.12
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.35 on September 28, 2026.
Profitability
Metric
Value
How it is calculated
Return on assets (ROA)
-189.2%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
EBITDA growth, 1y
-342.0%
EBITDA vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
10.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-6.5%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-2.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
175.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-23.3%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
23.0%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.57x
Current assets / current liabilities.
Quick ratio
0.42x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.17x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share
-$10.74
Cash from operations / diluted weighted shares.
Book value per share
-$0.83
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
Earnings yield
-132.0%
Net income / market cap (the inverse of P/E).
Was DNA X, Inc. profitable in fiscal 2025?
No. It reported a net loss of $20.7M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.